Compile Data Set for Download or QSAR
Report error Found 134 Enz. Inhib. hit(s) with all data for entry = 9540
TargetTyrosine-protein kinase Lck(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473171(US10844038, Example 43 B. | (3R,4S)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase HCK(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473171(US10844038, Example 43 B. | (3R,4S)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Fyn(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473171(US10844038, Example 43 B. | (3R,4S)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50 Table 13-20: The protocol calls for test compound of the invention to be incubated with kinase, substrate, cofactors, and radio-isotope-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Yes(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473174(US10844038, Example 43 A. | (3S,4R)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Yes(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473171(US10844038, Example 43 B. | (3R,4S)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Fgr(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473171(US10844038, Example 43 B. | (3R,4S)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50 Table 13-20: The protocol calls for test compound of the invention to be incubated with kinase, substrate, cofactors, and radio-isotope-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Lck(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473174(US10844038, Example 43 A. | (3S,4R)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase HCK(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473174(US10844038, Example 43 A. | (3S,4R)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Fyn(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473174(US10844038, Example 43 A. | (3S,4R)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50 Table 13-20: The protocol calls for test compound of the invention to be incubated with kinase, substrate, cofactors, and radio-isotope-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Blk(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473174(US10844038, Example 43 A. | (3S,4R)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50 Table 13-20: The protocol calls for test compound of the invention to be incubated with kinase, substrate, cofactors, and radio-isotope-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Yes(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473174(US10844038, Example 43 A. | (3S,4R)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Fgr(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473174(US10844038, Example 43 A. | (3S,4R)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50 Table 13-20: The protocol calls for test compound of the invention to be incubated with kinase, substrate, cofactors, and radio-isotope-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Blk(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473172(US10844038, Example 46 B. | (3R,4R)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50 Table 13-20: The protocol calls for test compound of the invention to be incubated with kinase, substrate, cofactors, and radio-isotope-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Lck(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473172(US10844038, Example 46 B. | (3R,4R)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Fgr(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473172(US10844038, Example 46 B. | (3R,4R)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50 Table 13-20: The protocol calls for test compound of the invention to be incubated with kinase, substrate, cofactors, and radio-isotope-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Fyn(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473172(US10844038, Example 46 B. | (3R,4R)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50 Table 13-20: The protocol calls for test compound of the invention to be incubated with kinase, substrate, cofactors, and radio-isotope-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Yes(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473172(US10844038, Example 46 B. | (3R,4R)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Yes(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473172(US10844038, Example 46 B. | (3R,4R)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Yes(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473175(US10844038, Example 46 A. | (3S,4S)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Yes(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473171(US10844038, Example 43 B. | (3R,4S)-3-((4-amino-3-...)
Affinity DataIC50: 5nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetDual specificity mitogen-activated protein kinase kinase 5(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473174(US10844038, Example 43 A. | (3S,4R)-3-((4-amino-3-...)
Affinity DataKd: <5nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetDual specificity mitogen-activated protein kinase kinase 5(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473176(US10844038, Example 38 | trans 1-((4-Methoxy-1,2-d...)
Affinity DataKd: <5nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetDual specificity mitogen-activated protein kinase kinase 5(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473176(US10844038, Example 38 | trans 1-((4-Methoxy-1,2-d...)
Affinity DataKd: <5nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetDual specificity mitogen-activated protein kinase kinase 5(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473182(US10844038, Example 30 | trans 3-((4-Amino-3-(4-ch...)
Affinity DataKd: <5nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetDual specificity mitogen-activated protein kinase kinase 5(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473172(US10844038, Example 46 B. | (3R,4R)-3-((4-amino-3-...)
Affinity DataKd: <5nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetDual specificity mitogen-activated protein kinase kinase 5(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473175(US10844038, Example 46 A. | (3S,4S)-3-((4-amino-3-...)
Affinity DataKd: <5nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetDual specificity mitogen-activated protein kinase kinase 5(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473171(US10844038, Example 43 B. | (3R,4S)-3-((4-amino-3-...)
Affinity DataKd: <5nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Fyn(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473171(US10844038, Example 43 B. | (3R,4S)-3-((4-amino-3-...)
Affinity DataIC50: 52nMAssay Description:IC50 Table 21: This assay is based on a competitive binder which can interact with a latent pocket formed only in the inactive state of the kinase. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetIsoform 2 of Tyrosine-protein kinase Fyn (T)(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473171(US10844038, Example 43 B. | (3R,4S)-3-((4-amino-3-...)
Affinity DataIC50: 52nMAssay Description:IC50 Table 22: This assay referred to as FlashPlate-based Protein Kinase Assay uses recombinant protein kinase and ATP concentration corresponding to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetIsoform 2 of Tyrosine-protein kinase Fyn (T)(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473174(US10844038, Example 43 A. | (3S,4R)-3-((4-amino-3-...)
Affinity DataIC50: 52nMAssay Description:IC50 Table 22: This assay referred to as FlashPlate-based Protein Kinase Assay uses recombinant protein kinase and ATP concentration corresponding to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Fyn(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473174(US10844038, Example 43 A. | (3S,4R)-3-((4-amino-3-...)
Affinity DataIC50: 52nMAssay Description:IC50 Table 21: This assay is based on a competitive binder which can interact with a latent pocket formed only in the inactive state of the kinase. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473187(US10844038, Example 55 | trans 3-((4-Amino-3-(2-am...)
Affinity DataIC50: 52nMAssay Description:IC50 Table 13-20: The protocol calls for test compound of the invention to be incubated with kinase, substrate, cofactors, and radio-isotope-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-4(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473172(US10844038, Example 46 B. | (3R,4R)-3-((4-amino-3-...)
Affinity DataIC50: 52nMAssay Description:IC50 Table 13-20: The protocol calls for test compound of the invention to be incubated with kinase, substrate, cofactors, and radio-isotope-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473176(US10844038, Example 38 | trans 1-((4-Methoxy-1,2-d...)
Affinity DataKd:  52nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473176(US10844038, Example 38 | trans 1-((4-Methoxy-1,2-d...)
Affinity DataKd:  52nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Yes(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473172(US10844038, Example 46 B. | (3R,4R)-3-((4-amino-3-...)
Affinity DataIC50: 52nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetDual specificity mitogen-activated protein kinase kinase 5(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473178(US10844038, Example 40 | trans 1-((4-(Benzyloxy)-1...)
Affinity DataKd:  52nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetDual specificity mitogen-activated protein kinase kinase 5(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473178(US10844038, Example 40 | trans 1-((4-(Benzyloxy)-1...)
Affinity DataKd:  52nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetDual specificity mitogen-activated protein kinase kinase 5(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473183(US10844038, Example 36 B. | (3R,4R)-3-((4-amino-3-...)
Affinity DataKd:  52nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetDual specificity mitogen-activated protein kinase kinase 5(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473181(US10844038, Example 28 | trans 3-((4-Amino-3-pheny...)
Affinity DataKd:  52nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473173(trans 3-((4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[...)
Affinity DataKd:  52nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473173(trans 3-((4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[...)
Affinity DataKd:  52nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Fyn(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473176(US10844038, Example 38 | trans 1-((4-Methoxy-1,2-d...)
Affinity DataIC50: 52nMAssay Description:IC50 Table 13-20: The protocol calls for test compound of the invention to be incubated with kinase, substrate, cofactors, and radio-isotope-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473172(US10844038, Example 46 B. | (3R,4R)-3-((4-amino-3-...)
Affinity DataKd:  52nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473171(US10844038, Example 43 B. | (3R,4S)-3-((4-amino-3-...)
Affinity DataKd:  52nMAssay Description:Kd: For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Blk(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473171(US10844038, Example 43 B. | (3R,4S)-3-((4-amino-3-...)
Affinity DataIC50: 52nMAssay Description:IC50 Table 13-20: The protocol calls for test compound of the invention to be incubated with kinase, substrate, cofactors, and radio-isotope-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Lyn(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473174(US10844038, Example 43 A. | (3S,4R)-3-((4-amino-3-...)
Affinity DataIC50: 52nMAssay Description:IC50 Table 13-20: The protocol calls for test compound of the invention to be incubated with kinase, substrate, cofactors, and radio-isotope-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473171(US10844038, Example 43 B. | (3R,4S)-3-((4-amino-3-...)
Affinity DataIC50: 52nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473172(US10844038, Example 46 B. | (3R,4R)-3-((4-amino-3-...)
Affinity DataIC50: 52nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

TargetTyrosine-protein kinase HCK(Human)
Sabila Biosciences

US Patent
LigandPNGBDBM473175(US10844038, Example 46 A. | (3S,4S)-3-((4-amino-3-...)
Affinity DataIC50: 52nMAssay Description:IC50: Methods for In Vitro Evaluation Assays known in the art for testing compounds are used to test compounds of this invention and to assess the bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
US Patent

Displayed 1 to 50 (of 134 total ) | Next | Last >>
Jump to: